MedTrace Logo

Optimization of Ureterolysis During Hysterectomy

NCT03123315 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-02-27

No results posted yet for this study

Summary

The purpose of this study is to improve the safety of surgery to remove a uterus (a hysterectomy) by better understanding where a patient's ureters lie.

Conditions

  • Hysterectomy

Interventions

DEVICE

Ureteral Illuminating Catheter

This is a very thin tube that goes into a ureter to more effectively find and track the ureter during surgeries

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Robert Debernardo, MD · Cleveland Clinic, Case Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-30
Primary Completion
2019-12-31
Completion
2020-06-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03123315 on ClinicalTrials.gov